New hip implant aims to cut repeat surgeries

NCT ID NCT04325022

Ongoing Disease control Sponsor: Smith & Nephew, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to check how well the implant holds up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OR3O Dual Mobility hip implant (a medical device)
What this could lead to: If successful, this could provide a more durable hip replacement option that reduces the need for repeat surgeries.
What could go wrong: This is an early-stage study with only 177 participants, and long-term results are not yet available. Implants can fail or cause complications like infection or dislocation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED DEGENERATION OF THE HIP JOINT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis of femoral head, primary, 1 femoral neck fracture hip fracture osteoarthritis osteoarthritis, hip rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED DEGENERATION OF THE HIP JOINT REVISION OF THE HIP JOINT

Contacts and locations

Locations

Calvary John James Hospital

Deakin, 2600, Australia
Hospital for Special Surgery

New York, New York, 10021, United States
Mater Health Services

Brisbane, Queensland, 4101, Australia
NYU Langone Health

New York, New York, 10003, United States
Queen Mary Hospital

Hong Kong, 2255, Hong Kong
Royal Perth Hospital

Perth, Western Australia, 6000, Australia
South Health Campus, Calgary

Calgary, Alberta, T3M127, Canada
St Michael's Hospital

Toronto, Ontario, M5C1R6, Canada
St. David's Center for Hip and Knee Replacement

Austin, Texas, 78705, United States
University of Kentucky

Lexington, Kentucky, 40508, United States
University of Nebraska Medical Center

Omaha, Nebraska, 69198, United States
Wake Forest School of Medicine

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.